Free Trial
ASX:BKL

Blackmores (BKL) Stock Price, News & Analysis

Blackmores logo

About Blackmores Stock (ASX:BKL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
75,759 shs
Average Volume
N/A
Market Capitalization
$1.84 billion
P/E Ratio
59.98
Dividend Yield
1.84%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.

Receive BKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blackmores and its competitors with MarketBeat's FREE daily newsletter.

BKL Stock News Headlines

How Trade Wars Are Creating Fresh Opportunities for Investors
Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”
Clover Corp Ltd UWA
See More Headlines

BKL Stock Analysis - Frequently Asked Questions

Blackmores Limited (ASX:BKL) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $1.99 earnings per share for the quarter, missing analysts' consensus estimates of $2.18 by $0.19. Blackmores had a trailing twelve-month return on equity of 7.96% and a net margin of 4.71%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Blackmores investors own include Citizens (CIA), Bonavista Energy Co. (BNP.TO) (BNP), Altium (ALU), OncoSil Medical (OSL), Pinnacle West Capital (PNW), Select Harvests (SHV) and ECN Capital (ECN).

Company Calendar

Last Earnings
2/19/2019
Today
5/25/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
ASX:BKL
CIK
N/A
Fax
N/A
Employees
1,200
Year Founded
N/A

Profitability

Trailing P/E Ratio
59.98
Forward P/E Ratio
N/A
P/E Growth
1.31
Net Income
$34.61 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$645 million
Price / Cash Flow
39.12
Book Value
A$21.08 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.84 billion
Optionable
Not Optionable
Beta
0.61
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:BKL) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners